WD Rutherford LLC Sells 1,266 Shares of Intuitive Surgical, Inc. $ISRG

WD Rutherford LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,056 shares of the medical equipment provider’s stock after selling 1,266 shares during the quarter. WD Rutherford LLC’s holdings in Intuitive Surgical were worth $429,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Main Street Group LTD purchased a new position in Intuitive Surgical in the first quarter valued at $30,000. North Point Portfolio Managers Corp OH purchased a new position in Intuitive Surgical during the 3rd quarter worth $27,000. Compass Wealth Management LLC purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at approximately $29,000. Evergreen Advisors LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $35,000. Finally, Compass Financial Management LLC acquired a new position in Intuitive Surgical during the second quarter worth $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, Director Gary S. Guthart sold 20,095 shares of the stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the transaction, the director owned 1,204,530 shares in the company, valued at $543,977,793.30. This trade represents a 1.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 38,684 shares of company stock worth $16,770,301. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Down 1.3%

ISRG stock opened at $445.88 on Wednesday. The company has a 50-day simple moving average of $398.31 and a 200 day simple moving average of $436.15. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The company had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical’s revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.40 EPS. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Oppenheimer reissued an “outperform” rating and issued a $500.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 21st. BTIG Research restated a “buy” rating and issued a $454.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Barclays reaffirmed an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. Finally, HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price on the stock. in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $493.54.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly constructive: the average brokerage recommendation is equivalent to a Buy, while the reported consensus price target of $493.54 is above recent trading levels. However, the article cautions that sell-side ratings can be overly optimistic. Wall Street bullish views on ISRG
• Positive Sentiment: Analysts have been raising earnings estimates, and Zacks highlighted ISRG’s growth profile. The company’s latest quarterly results provide fundamental support, with revenue up 21.7% year over year to $3.05 billion and earnings of $3.00 per share versus a $2.65 consensus estimate. Higher earnings estimates
• Neutral Sentiment: ISRG is attracting substantial investor attention, which may increase trading activity but does not necessarily signal a change in business fundamentals. Reported short interest of zero shares and a zero-day days-to-cover ratio also appear inconsistent with the description of a significant increase, limiting the data’s usefulness. ISRG trending-stock analysis
• Negative Sentiment: Several insiders sold shares under pre-arranged Rule 10b5-1 plans. Director Gary Guthart sold approximately $9.1 million, while a vice president, senior vice president and another director also reduced their holdings. Although planned sales are not necessarily bearish, the cluster may weigh on sentiment. ISRG insider selling
• Negative Sentiment: Valuation remains a key risk. ISRG trades at roughly 54 times earnings and a PEG ratio above 3, leaving limited room for execution disappointments. The stock’s decline below its 200-day moving average may also indicate near-term technical weakness.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.